Status:
COMPLETED
Efficacy and Safety of Repeated-use Middle Cut Off Membrane Dialyzers in Hemodialysis Patients
Lead Sponsor:
Khon Kaen University
Conditions:
Hemodialysis
Hemodialysis Treatment
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare the efficacy of uremic toxin and inflammatory cytokine clearance by using reprocessing middle cutoff membrane (MCO) dialyzer in chronic hemodialysis patie...
Detailed Description
Study design and population The single - center prospective open-label randomize control trial was conducted in prevalence HD patients at the Srinagarind Hospital, Khon Kaen University between January...
Eligibility Criteria
Inclusion
- chronic hemodialysis with dialysis vintage more than 3 months
- hemodialysis via permanent vascular access (fistula or graft)
- adequate hemodialysis define with spKt/V \> 1.8 and \> 1.2 per session in twice and thrice weekly hemodialysis, respectively
Exclusion
- preganancy
- hemodialysis vascular access dysfunction
- blood transmitted infection
- advanced malignancy or severe morbidity with life expectancy less than 1 year
- severe dialyzer reaction
- receive immunosuppressive drug
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06950944
Start Date
January 1 2024
End Date
April 30 2024
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Khon Kaen University
Khon Kaen, Changwat Khon Kaen, Thailand, 40002